Working… Menu

Safety Study of Intranasal Etripamil for the Termination of Spontaneous Episodes of Paroxysmal Supraventricular Tachycardia (PSVT). NODE-302

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03635996
Recruitment Status : Completed
First Posted : August 17, 2018
Last Update Posted : March 29, 2021
Medpace, Inc.
Information provided by (Responsible Party):
Milestone Pharmaceuticals Inc.

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : November 13, 2020
Actual Study Completion Date : November 13, 2020
Certification/Extension First Submitted : March 23, 2021